LEUCEMIA MIELÓIDE AGUDA E O TRATAMENTO COM TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS: UMA EVOLUÇÃO TERAPÊUTICA

Abstract

This is a subject considered promising. A treatment approach that promises to revolutionize the lives of patients with acute myeloid leukemia (AML). This disease, little known to many people, is characterized by the abnormal growth of bone cells. Possible treatments become challenging due to recovery rates and associated toxicities. Despite the advantages, challenges such as careful patient selection and selection of appropriate sources of stem cells must be faced to improve treatment efficacy, hematopietic stem cell therapy may offer an innovative alternative that allows bone marrow regeneration by promoting responses significant for patients. Acute Myeloid Leukemia (AML) is a rare disease with devastating effects on the survival statistics of patients with cancer. Its treatment consists of achieving complete remission through chemotherapy and remission consolidation (CR) (chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation (HSCT). The work aims to better understand AML and the importance of hematopoietic stem cell transplantation in the treatment of patients with acute myeloid leukemia. It still seeks to understand the real advantages and disadvantages of this therapy in terms of providing a better quality of survival.